Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas von Hahn

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Clinics in Liver Disease|August 27, 2011
Second-wave protease inhibitors: choosing an heirSandra Ciesek, Thomas von Hahn, Michael P Manns
Expert Review of Gastroenterology & Hepatology|February 9, 2010
Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approachesThomas von Hahn, Eike Steinmann, Sandra Ciesek, et al.
Innere Medizin (Heidelberg, Germany)|December 23, 2025
[How do we ensure quality in endoscopy?]Natascha Wehnert, Matthias Kahl, Benjamin Schmidt, et al.
Current Opinion in Virology|September 7, 2023
Genetic and pharmacological perturbation of hepatitis-C virus entryBelén Carriquí-Madroñal, Lisa Lasswitz, Thomas von Hahn, et al.
Digestion|March 24, 2005
Management of severe refractory adult autoimmune enteropathy with infliximab and tacrolimusThomas von Hahn, Dieter Stopik, Martin Koch, et al.
Reviews in Medical Virology|May 18, 2016
Prevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapyStephanie Pfaender, Thomas von Hahn, Joerg Steinmann, et al.
Visceral Medicine|April 8, 2024
Parenchyma-Preserving Hepatectomy in Perihilar Cholangiocarcinoma: A Chance for Critical Patients?Tobias S Bröring, Kim C Wagner, Thomas von Hahn, et al.
Endoscopy International Open|January 8, 2024
Provider-reported use of butylscopolamine in gastrointestinal endoscopy in GermanyOctavia Ullmann, Daniel Ranti, Ekaterini Georgiadou, et al.
United European Gastroenterology Journal|May 6, 2020
Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitisMartha M Kirstein, Thorsten Book, Michael P Manns, et al.
Antiviral Research|November 12, 2013
Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralizationMaximilian Deest, Sandra Westhaus, Eike Steinmann, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Clinics in Liver Disease|August 27, 2011
Second-wave protease inhibitors: choosing an heirSandra Ciesek, Thomas von Hahn, Michael P Manns
Expert Review of Gastroenterology & Hepatology|February 9, 2010
Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approachesThomas von Hahn, Eike Steinmann, Sandra Ciesek, et al.
Innere Medizin (Heidelberg, Germany)|December 23, 2025
[How do we ensure quality in endoscopy?]Natascha Wehnert, Matthias Kahl, Benjamin Schmidt, et al.
Current Opinion in Virology|September 7, 2023
Genetic and pharmacological perturbation of hepatitis-C virus entryBelén Carriquí-Madroñal, Lisa Lasswitz, Thomas von Hahn, et al.
Digestion|March 24, 2005
Management of severe refractory adult autoimmune enteropathy with infliximab and tacrolimusThomas von Hahn, Dieter Stopik, Martin Koch, et al.
Reviews in Medical Virology|May 18, 2016
Prevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapyStephanie Pfaender, Thomas von Hahn, Joerg Steinmann, et al.
Visceral Medicine|April 8, 2024
Parenchyma-Preserving Hepatectomy in Perihilar Cholangiocarcinoma: A Chance for Critical Patients?Tobias S Bröring, Kim C Wagner, Thomas von Hahn, et al.
Endoscopy International Open|January 8, 2024
Provider-reported use of butylscopolamine in gastrointestinal endoscopy in GermanyOctavia Ullmann, Daniel Ranti, Ekaterini Georgiadou, et al.
United European Gastroenterology Journal|May 6, 2020
Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitisMartha M Kirstein, Thorsten Book, Michael P Manns, et al.
Antiviral Research|November 12, 2013
Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralizationMaximilian Deest, Sandra Westhaus, Eike Steinmann, et al.
Pageof 9